NCT07227402
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07227402
Title A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033) (LITESPARK-033)
Acronym LITESPARK-033
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries ARG

Facility Status City State Zip Country Details
Asociación de Beneficencia Hospital Sirio Libanés ( Site 0205) RECRUITING Caba Buenos Aires C1419AHN Argentina Details
Queen Mary Hospital ( Site 2201) RECRUITING Hong Kong Hong Kong Details
China Medical University Hospital ( Site 2603) RECRUITING Taichung 40447 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field